Strs Ohio Keros Therapeutics, Inc. Transaction History

Strs Ohio

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	BUY	$37.26 - $51.01 $14,904 - $20,404	400 Added 7.55%	5,700 $229,000
Q1 2023 Aug 02, 2023	SELL	$41.44 - $59.32 $16,576 - $23,728	-400 Reduced 7.02%	5,300 $226,000
Q3 2022 Oct 27, 2022	BUY	$27.8 - $40.12 $147,340 - $212,636	5,300 New	5,300 $199,000
Q3 2021 Oct 22, 2021	SELL	$29.27 - $43.71 $58,540 - $87,420	-2,000 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$42.4 - $70.11 $8,480 - $14,022	200 Added 11.11%	2,000 $84,000
Q2 2020 Jul 23, 2020	BUY	$20.08 - $40.39 $36,144 - $72,702	1,800 New	1,800 $67,000

174

30.3M

76.8K

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $403M
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.